Global Novel Drug Delivery Systems for Cancer Therapy Market Growth, Trends, and Forecasts 2015-2025

Global Novel Drug Delivery Systems for Cancer Therapy Market Growth, Trends, and Forecasts 2015-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Novel Drug Delivery Systems for Cancer Therapy will have significant change from previous year. By the most conservative estimates of global Novel Drug Delivery Systems for Cancer Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Novel Drug Delivery Systems for Cancer Therapy market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Novel Drug Delivery Systems for Cancer Therapy market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Novel Drug Delivery Systems for Cancer Therapy, covering the supply chain analysis, impact assessment to the Novel Drug Delivery Systems for Cancer Therapy market size growth rate in several scenarios, and the measures to be undertaken by Novel Drug Delivery Systems for Cancer Therapy companies in response to the COVID-19 epidemic.

Segmentation by product type:
Embolization Particles – Drug Eluting Beads
Polyvinyl Alcohol Particles
Microspheres
Gelatin-Based Embolization Devices
Selective Internal Radiation Therapy
Holmium-Based Microspheres
Liquid Embolics – Onyx
Other

Segmentation by Application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
Rest of Americas
APAC
China
Japan
Korea
Taiwan
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Rest of APAC
Europe
Germany
France
UK
Russia
Italy
Benelux
Nordic
Rest of Europe
MENA
Saudi Arabia
UAE
Turkey
South Africa
Egypt

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.
Advanced Medical Isotope Corporation
EmboMedics, Inc.
Bind Therapeutics
BTG plc
CeloNova BioSciences, Inc.
Boston Scientific Corporation
Covidien, plc
Cook Medical, Inc.
Eckert & Ziegler BEBIG
Cospheric LLC
Sirtex Medical, Inc.
Terumo Corporation
Kobo Products, Inc.
Nanobiotix
Mo-Sci Corporation
Polysciences, Inc.
Merit Medical Systems, Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.


1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Novel Drug Delivery Systems for Cancer Therapy?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Novel Drug Delivery Systems for Cancer Therapy Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 Market Overview
2.1.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size and Forecast, 2015-2025
2.1.2 Novel Drug Delivery Systems for Cancer Therapy Market Size and Forecast by Region, 2015 VS 2020 VS 2025
2.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Size and Forecast by Regions, 2015-2025 ($ millions)
2.3 Americas Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth, 2015-2025 ($ millions)
2.4 APAC Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth, 2015-2025 ($ millions)
2.5 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth, 2015-2025 ($ millions)
2.6 MENA Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth, 2015-2025 ($ millions)
3 Novel Drug Delivery Systems for Cancer Therapy Market Size by Player
3.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Player
3.1.1 Global Top Players Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2020E ($ millions)
3.1.2 Global Top Novel Drug Delivery Systems for Cancer Therapy Players Market Share, 2018-2020E
3.2 Global Key Novel Drug Delivery Systems for Cancer Therapy Players Rank in 2019
3.3 Global Key Novel Drug Delivery Systems for Cancer Therapy Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
3.4.1 Competition Landscape Analysis
3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion
4 Novel Drug Delivery Systems for Cancer Therapy Segment by Type
4.1 Overview
4.1.1 Embolization Particles – Drug Eluting Beads
4.1.2 Polyvinyl Alcohol Particles
4.1.3 Microspheres
4.1.4 Gelatin-Based Embolization Devices
4.1.5 Selective Internal Radiation Therapy
4.1.6 Holmium-Based Microspheres
4.1.7 Liquid Embolics – Onyx
4.1.8 Other
4.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Type, 2015-2025 ($ millions)
4.3 Embolization Particles – Drug Eluting Beads Market Size by Region, 2015-2025 ($ millions)
4.4 Polyvinyl Alcohol Particles Market Size by Region, 2015-2025 ($ millions)
4.5 Microspheres Market Size by Region, 2015-2025 ($ millions)
4.6 Gelatin-Based Embolization Devices Market Size by Region, 2015-2025 ($ millions)
4.7 Selective Internal Radiation Therapy Market Size by Region, 2015-2025 ($ millions)
4.8 Holmium-Based Microspheres Market Size by Region, 2015-2025 ($ millions)
4.9 Liquid Embolics – Onyx Market Size by Region, 2015-2025 ($ millions)
4.10 Other Market Size by Region, 2015-2025 ($ millions)
5 Novel Drug Delivery Systems for Cancer Therapy Segment by Application
5.1 Overview
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Others
5.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Application, 2015-2025 ($ millions)
5.3 Hospitals Market Size by Region, 2015-2025 ($ millions)
5.4 Clinics Market Size by Region, 2015-2025 ($ millions)
5.5 Others Market Size by Region, 2015-2025 ($ millions)
6 Americas
6.1 Americas Novel Drug Delivery Systems for Cancer Therapy Market Size by Country
6.2 United States Novel Drug Delivery Systems for Cancer Therapy Market Size
6.3 Canada Novel Drug Delivery Systems for Cancer Therapy Market Size
6.4 Mexico Novel Drug Delivery Systems for Cancer Therapy Market Size
6.5 Brazil Novel Drug Delivery Systems for Cancer Therapy Market Size
7 APAC
7.1 APAC Novel Drug Delivery Systems for Cancer Therapy Market Size by Regions
7.2 China Novel Drug Delivery Systems for Cancer Therapy Market Size
7.3 Japan Novel Drug Delivery Systems for Cancer Therapy Market Size
7.4 Korea Novel Drug Delivery Systems for Cancer Therapy Market Size
7.5 Taiwan Novel Drug Delivery Systems for Cancer Therapy Market Size
7.6 India Novel Drug Delivery Systems for Cancer Therapy Market Size
7.7 Australia Novel Drug Delivery Systems for Cancer Therapy Market Size
7.8 Indonesia Novel Drug Delivery Systems for Cancer Therapy Market Size
7.9 Thailand Novel Drug Delivery Systems for Cancer Therapy Market Size
7.10 Malaysia Novel Drug Delivery Systems for Cancer Therapy Market Size
7.11 Philippines Novel Drug Delivery Systems for Cancer Therapy Market Size
7.12 Vietnam Novel Drug Delivery Systems for Cancer Therapy Market Size
8 Europe
8.1 Europe Novel Drug Delivery Systems for Cancer Therapy by Country
8.2 Germany Novel Drug Delivery Systems for Cancer Therapy Market Size
8.3 France Novel Drug Delivery Systems for Cancer Therapy Market Size
8.4 UK Novel Drug Delivery Systems for Cancer Therapy Market Size
8.5 Russia Novel Drug Delivery Systems for Cancer Therapy Market Size
8.6 Italy Novel Drug Delivery Systems for Cancer Therapy Market Size
8.7 Australia Novel Drug Delivery Systems for Cancer Therapy Market Size
8.8 Benelux Novel Drug Delivery Systems for Cancer Therapy Market Size
8.9 Nordic Novel Drug Delivery Systems for Cancer Therapy Market Size
9 MENA
9.1 MENA & Africa Novel Drug Delivery Systems for Cancer Therapy by Country
9.2 Saudi Arabia Novel Drug Delivery Systems for Cancer Therapy Market Size
9.3 UAE Novel Drug Delivery Systems for Cancer Therapy Market Size
9.4 Turkey Novel Drug Delivery Systems for Cancer Therapy Market Size
9.5 South Africa Novel Drug Delivery Systems for Cancer Therapy Market Size
9.6 Egypt Novel Drug Delivery Systems for Cancer Therapy Market Size
10 Market Drivers, Challenges and Trends
10.1 Market Drivers and Impact
10.1.1 Growing Demand from Key Regions
10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends
11 Key Players Analysis
11.1 Advanced Medical Isotope Corporation
11.1.1 Advanced Medical Isotope Corporation Company Information
11.1.2 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.1.4 Advanced Medical Isotope Corporation Main Business Overview
11.1.5 Advanced Medical Isotope Corporation Latest Developments
11.2 EmboMedics, Inc.
11.2.1 EmboMedics, Inc. Company Information
11.2.2 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.2.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.2.4 EmboMedics, Inc. Main Business Overview
11.2.5 EmboMedics, Inc. Latest Developments
11.3 Bind Therapeutics
11.3.1 Bind Therapeutics Company Information
11.3.2 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.3.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.3.4 Bind Therapeutics Main Business Overview
11.3.5 Bind Therapeutics Latest Developments
11.4 BTG plc
11.4.1 BTG plc Company Information
11.4.2 BTG plc Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.4.4 BTG plc Main Business Overview
11.4.5 BTG plc Latest Developments
11.5 CeloNova BioSciences, Inc.
11.5.1 CeloNova BioSciences, Inc. Company Information
11.5.2 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.5.4 CeloNova BioSciences, Inc. Main Business Overview
11.5.5 CeloNova BioSciences, Inc. Latest Developments
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Company Information
11.6.2 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.6.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.6.4 Boston Scientific Corporation Main Business Overview
11.6.5 Boston Scientific Corporation Latest Developments
11.7 Covidien, plc
11.7.1 Covidien, plc Company Information
11.7.2 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.7.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.7.4 Covidien, plc Main Business Overview
11.7.5 Covidien, plc Latest Developments
11.8 Cook Medical, Inc.
11.8.1 Cook Medical, Inc. Company Information
11.8.2 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.8.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.8.4 Cook Medical, Inc. Main Business Overview
11.8.5 Cook Medical, Inc. Latest Developments
11.9 Eckert & Ziegler BEBIG
11.9.1 Eckert & Ziegler BEBIG Company Information
11.9.2 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.9.3 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.9.4 Eckert & Ziegler BEBIG Main Business Overview
11.9.5 Eckert & Ziegler BEBIG Latest Developments
11.10 Cospheric LLC
11.10.1 Cospheric LLC Company Information
11.10.2 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.10.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.10.4 Cospheric LLC Main Business Overview
11.10.5 Cospheric LLC Latest Developments
11.11 Sirtex Medical, Inc.
11.11.1 Sirtex Medical, Inc. Company Information
11.11.2 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.11.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.11.4 Sirtex Medical, Inc. Main Business Overview
11.11.5 Sirtex Medical, Inc. Latest Developments
11.12 Terumo Corporation
11.12.1 Terumo Corporation Company Information
11.12.2 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.12.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.12.4 Terumo Corporation Main Business Overview
11.12.5 Terumo Corporation Latest Developments
11.13 Kobo Products, Inc.
11.13.1 Kobo Products, Inc. Company Information
11.13.2 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.13.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.13.4 Kobo Products, Inc. Main Business Overview
11.13.5 Kobo Products, Inc. Latest Developments
11.14 Nanobiotix
11.14.1 Nanobiotix Company Information
11.14.2 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.14.4 Nanobiotix Main Business Overview
11.14.5 Nanobiotix Latest Developments
11.15 Mo-Sci Corporation
11.15.1 Mo-Sci Corporation Company Information
11.15.2 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.15.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.15.4 Mo-Sci Corporation Main Business Overview
11.15.5 Mo-Sci Corporation Latest Developments
11.16 Polysciences, Inc.
11.16.1 Polysciences, Inc. Company Information
11.16.2 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.16.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.16.4 Polysciences, Inc. Main Business Overview
11.16.5 Polysciences, Inc. Latest Developments
11.17 Merit Medical Systems, Inc.
11.17.1 Merit Medical Systems, Inc. Company Information
11.17.2 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offered
11.17.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue and YoY Growth, 2018-2020E
11.17.4 Merit Medical Systems, Inc. Main Business Overview
11.17.5 Merit Medical Systems, Inc. Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook